![Alberto Henere](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Alberto Henere
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Inveready Asset Management SGEIC SA
![]() Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready Asset Management SGEIC SA (Inveready) is a private equity and venture capital subsidiary of Inveready Capital Co. SL founded in 2008 by Joseph Maria Echarri Torres. The firm is headquartered in San Sebastian, Spain.
7
| Subsidiary | Investment Managers | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Alberto Henere
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CHEVRON CORPORATION | Integrated Oil | Private Equity Investor | |
Indiana University | College/University | Graduate Degree | |
INSEAD | College/University | Masters Business Admin | |
University of Barcelona | College/University | Undergraduate Degree Undergraduate Degree | |
London Business School | College/University | Masters Business Admin | |
Escuela Superior de Administración y Dirección de Empresas | College/University | Undergraduate Degree | |
HarbourVest Partners (UK) Ltd. | Investment Managers | Private Equity Analyst | |
Axon Partners Group Investment SGEIC SA
![]() Axon Partners Group Investment SGEIC SA Investment ManagersFinance Axon Partners Group Investment SGEIC SA (Axon Partners Group) is a private equity and venture capital firm founded in 2006 by Julio Villalobos Rius. The firm is headquartered in Madrid, Spain with offices across the globe. | Investment Managers | Private Equity Investor | |
Agrasys SL
![]() Agrasys SL BiotechnologyHealth Technology Agrasys SL develops and commercialize crops and cereals. It offers Tritordeum, a non genetic modification cereals and developed for human nutrition. The company was founded in 2005 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Ability Pharmaceuticals SL
![]() Ability Pharmaceuticals SL BiotechnologyHealth Technology Ability Pharmaceuticals SL operates as a clinical stage drug discovery and development biopharmaceutical firm. It develops human therapeutics to treat cancer and other indications with unmet medical needs. The company was founded by Carles Domènech Garcia Jordi Espadaler Mazo in November 2009 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
IFFE FUTURA, S.A. | Real Estate Investment Trusts | Director/Board Member | |
Zera Intein Protein Solutions SL
![]() Zera Intein Protein Solutions SL BiotechnologyHealth Technology Zera Intein Protein Solutions SL develops and commercializes biomedical technologies, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors. Its proprietary technologies include Zera and Splittera. Zera technology is composed of self-assembler peptides for DNA vaccines, carrier-free enzyme immobilization, and biopharmaceutical protein production. Splittera refers to Split Intein technology which includes trans-splicing, cyclization, and cleavage reactions. The company was founded on January 30, 2015 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Feedzai Spain SL
![]() Feedzai Spain SL Packaged SoftwareTechnology Services Feedzai Spain SL manufactures software of Cloud security solutions. It offers bugThreats Cyberthreat Intelligence Platform, bugBlast Next-gen AppSec Platform, bugScout SCA and bugFraud Defense. The company was founded on November 12, 2010 by Pablo de la Riva and is headquartered in Alcobendas, Spain. | Packaged Software | Director/Board Member | |
Innoup Farma SL
![]() Innoup Farma SL BiotechnologyHealth Technology InnoUp Farma SL develops nanotechnology-based solutions for the administration of oral drugs. It offers anti-cancer drugs with low oral bioavailability. The company was founded by Maite Agueros Bazo, Manuel Rodriguez Mariscal and Juan Manuel Irache Garreta and is headquartered in Noain, Spain. | Biotechnology | Director/Board Member | |
Avizorex Pharma SL
![]() Avizorex Pharma SL Medical/Nursing ServicesHealth Services Avizorex Pharma SL develops drugs for the treatment of the dry eye disease. The company was founded by Carlos Belmonte and Sauri Patrick Tresserras in July, 2013 and is headquartered in Barcelona, Spain. | Medical/Nursing Services | Director/Board Member | |
AptaTargets SL
![]() AptaTargets SL Pharmaceuticals: MajorHealth Technology AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
Photoslurp SL
![]() Photoslurp SL Internet Software/ServicesTechnology Services Photoslurp SL operates a visual commerce and marketing platform, which searches for and integrates customer''s photos from social media into online shopping. It offers visual commerce, shoppable Instagram, engagement tools, and analytics suite solutions. The company was founded by Benjamin Ikbal Heinkel and Casas Eulogi Bordas and is headquartered in Barcelona, Spain. | Internet Software/Services | Director/Board Member | |
Movil Access SL
![]() Movil Access SL Miscellaneous Commercial ServicesCommercial Services Movil Access SL is an online platform that conducts public opinion surveys and market studies. The company is based in Barcelona, Spain. The Spanish company was founded in 2016 by Rosillo Borja Ormaechea, Josa Ferrer, and they have been the CEOs since 2016. | Miscellaneous Commercial Services | Director/Board Member | |
Biotechnology Development for Industry in Pharmaceuticals SLU
![]() Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
AmacaThera, Inc.
![]() AmacaThera, Inc. Medical SpecialtiesHealth Technology AmacaThera, Inc. is biotechnology company, which engages in the development and commercialization of injectable hydrogel platform technology. Its platform addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. The company was founded by Molly S. Soichet and Mike Cooke and is headquartered in Toronto, Canada. | Medical Specialties | Director/Board Member | |
EDESA BIOTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
Oxolife SL
![]() Oxolife SL BiotechnologyHealth Technology Oxolife SL operates as an biotech company focused on treating female infertility. The company was founded by Agn?s Arbat and Ignasi Canals in 2013 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Connecta Therapeutics SL
![]() Connecta Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Connecta Therapeutics SL is an innovation-oriented, R&D-intensive organization committed to developing innovative treatments for patients. Connecta Therapeutics is based in Barcelona, ES. The Spanish company strongly believes in improving the lives of patients and their families and understands the importance of teamwork and collaboration to achieve their goals. The company was founded in 2019 by Josep Prous, David Prous, and Jordi Fàbrega. Jordi Fàbrega has been the CEO since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
Antalgenics SL
![]() Antalgenics SL BiotechnologyHealth Technology Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis. | Biotechnology | Director/Board Member | |
Tikehau Capital UK Ltd.
![]() Tikehau Capital UK Ltd. Financial ConglomeratesFinance Part of Tikehau Capital Advisors SAS, Tikehau Capital UK Ltd. is an investment holding company. Tikehau Capital UK Ltd. is based in London, UK. Founded in 2013, Tikehau Capital functions as an investment holding company. | Financial Conglomerates | Private Equity Analyst |
Statistik
International
Spanien | 17 |
Vereinigtes Königreich | 4 |
Vereinigte Staaten | 3 |
Kanada | 3 |
Frankreich | 2 |
Sektoral
Health Technology | 10 |
Consumer Services | 6 |
Finance | 5 |
Commercial Services | 4 |
Technology Services | 3 |
Operativ
Director/Board Member | 17 |
Private Equity Analyst | 5 |
Private Equity Investor | 4 |
Undergraduate Degree | 3 |
Masters Business Admin | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Alberto Henere
- Unternehmensverbindungen